About Chronomics
Chronomics is a company based in Norwich (United Kingdom) founded in 2017. Chronomics has raised $1.43 million across 1 funding round from investors including Anthemis Group and SOSV. The company has 28 employees as of December 31, 2021. Chronomics offers products and services including Sample Collection Kits, Lab Testing, Partner Dashboard, and Digital Patient Experience. Chronomics operates in a competitive market with competitors including Chroma Medicine, Reaction Biology, FOXO Technologies, Inherent Biosciences and EpiCypher, among others.
- Headquarter Norwich, United Kingdom
- Employees 28 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chronomics Limited
- Date of Incorporation 20 Dec, 2017
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.43 M (USD)
in 1 rounds
-
Latest Funding Round
$1.43 M (USD), Seed
Jan 10, 2019
-
Investors
Anthemis Group
& 1 more
-
Employee Count
28
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Chronomics
Chronomics offers a comprehensive portfolio of products and services, including Sample Collection Kits, Lab Testing, Partner Dashboard, and Digital Patient Experience.
Kits for efficient sample collection in healthcare diagnostics
Services for laboratory analysis and biomarker validation
Dashboard for managing diagnostic logistics and fulfillment
Platform for personalized diagnostics and health monitoring
People of Chronomics
Unlock access to complete
Funding Insights of Chronomics
Chronomics has successfully raised a total of $1.43M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.43 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Chronomics
Chronomics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Anthemis Group and SOSV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early and growth-stage startups are funded by Anthemis Group.
|
Locked | Locked | Locked | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Locked | Locked | Locked |
Investor details for Chronomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chronomics
Investment portfolio details for Chronomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chronomics
Detailed financials for Chronomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chronomics Comparisons
Peer comparison for Chronomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chronomics
Chronomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Chroma Medicine, Reaction Biology, FOXO Technologies, Inherent Biosciences and EpiCypher, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Epigenetic editing platform is developed for genomic medicines.
|
|
| Locked | Locked | Locked |
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
|
| Locked | Locked | Locked |
Epigenetic biomarkers are discovered and developed via AI platforms.
|
|
| Locked | Locked | Locked |
Epigenetic diagnostics and therapeutics for complex diseases are developed.
|
|
| Locked | Locked | Locked |
Epigenetic kits, reagents, and assays are supplied for research applications.
|
Detailed competitors of Chronomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chronomics
Complete news archive for Chronomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chronomics
Chronomics was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Chronomics is headquartered in Norwich, United Kingdom. It is registered at Norwich, Norfolk, United Kingdom.
Chronomics is a funded company, having raised a total of $1.43M across 1 funding round to date.
As of Dec 31, 2021, the latest employee count at Chronomics is 28.
Chronomics was founded in 2017 in Norwich, United Kingdom, as a provider in the health technology sector. An online digital platform is operated for managing epigenetics data. Services include DNA-based epigenetic testing for proactive healthcare insights, with samples collected through home-based saliva kits. Operations focus on accessible analysis without requiring clinical visits, supporting users in the UK and potentially beyond.
Chronomics's top competitors include Chroma Medicine, FOXO Technologies and EpiCypher.
Chronomics offers Sample Collection Kits, Lab Testing, Partner Dashboard, and Digital Patient Experience.
Chronomics has 2 investors. Key investors include Anthemis Group, and SOSV.